You
are here: Home: CCU 3 | 2003: Faculty Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of NL Communications Inc to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Norman Wolmark, MD |
No financial interests or affiliations to disclose |
John Zalcberg, MB, BS, PhD, FRACP |
Honorarium: Sanofi-Synthelabo Inc, Roche Laboratories Inc, Novartis
Pharmaceuticals Corporation, Pharmacia Corporation, Aventis
Pharmaceuticals Inc
Board Member: Progen Industries |
Yehuda Patt, MD |
Grants/Research Support: Roche Laboratories Inc, Sanofi-Synthelabo Inc,
Pharmacia Corporation
Honorarium: Roche Laboratories Inc, Sanofi-Synthelabo Inc |
Lawrence D Wagman, MD, FACS |
No financial interests or affiliations to disclose |
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. NL Communications Inc does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
|
|
Home
Faculty
Disclosures
A CME Audio Series and Activity
Editor's office
|